Open-market purchases of Parabilis Medicines, Inc. (PBLS) stock by its own executives, directors and 10% owners — every Form 4 buy of $250K or more that SPX Lens's daily insider scan has recorded, newest first.
| Scan | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| Jul 23, 2026 | RA Capital Management, L.P. (Peter Kolchinsky / Rajeev M. Shah)10% Owner / Director | $6.92M | Added | |||
| 6 open-market transactions Jul 20–22 at weighted avg prices $27.13–$30.00/share. RA Capital Healthcare Fund LP and RA Capital Nexus Fund III LP purchased jointly; total beneficial ownership ~29.2M shares. Stock now $30.81 (+8.9% vs $28.29 blended avg buy price). No specific earnings catalyst identified; aggressive accumulation at rising prices. | ||||||
| Jul 1, 2026 | Guy Levy10% Owner | $10.0M | New stake | |||
| Bought 500,000 shares at $20.00 (IPO price, June 11, 2026). Late Form 4 filing — 18 days after trade date, coinciding with IPO lock-up window. Stock now at $27.37 (+36.9% since buy). RA Capital also reported a ~$423M purchase in the same Form 6-K/13D cluster. Fresh IPO on June 10, 2026. | ||||||
| Jun 16, 2026 | Alan Sebulsky / Apothecary Capital LLCDirector | $250K | New stake | |||
| Director-linked LLC bought 12,500 shares at exactly $20.00 (IPO price); spot $25.01 (+25.1%). Parabilis Medicines (Helicon peptides / oncology) IPO'd June 2026. Purchase at IPO price right after listing; shares held indirectly, Sebulsky disclaims ownership beyond pecuniary interest. Transaction dated June 11, filed June 15. | ||||||
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.